Related Funds
Fund Name | Location |
Alexia Ventures | Brazil, São Paulo, São Paulo |
Amelia Investments | - |
BAE Systems | Farnborough, Hampshire, United Kingdom |
Bellingham Angel Investors | Bellingham, United States, Washington |
Cube Infrastructure Managers | Luxembourg, Luxembourg |
Goal Structured Solutions | California, San Diego, United States |
IntelleGrow | India, Maharashtra, Mumbai |
Kaedan Capital | Israel, Tel Aviv, Tel Aviv |
Kempen & Co | Amsterdam, Noord-Holland, The Netherlands |
LVMH Luxury Ventures | France, Ile-de-France, Paris |
Millennium Network | New York, New York, United States |
Movistar | Community of Madrid, Madrid, Spain |
Next Holding | Firenze, Italy, Toscana |
Patina Brands | - |
Sanderling Ventures | California, San Mateo, United States |
Second Technology Capital Investors | Arizona, Phoenix, United States |
Successful Ventures | Barcelona, Catalonia, Spain |
Wenzhou Dongchuang Xinhui | - |
Yakumi | Japan, Tokyo |
Zhongtai Securities | China, Jinan, Shandong |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Ability biologics | $18M | 18 Jun 2024 | Quebec, Quebec, Canada | ||
Simmunome AI | $1M | 18 Sep 2023 | Montreal, Quebec, Canada | ||
Flare Systems | $2M | 30 Nov 2022 | Montreal, Quebec, Canada | ||
Domain Therapeutics | $46M | 10 May 2022 | France, Grand Est, France | ||
DrugBank | $7M | 11 Apr 2022 | Edmonton, Canada | ||
Cascador Health | $4M | 25 Mar 2022 | Oost-Vlaanderen, East Flanders, Belgium | ||
HypnoVR | $5M | 07 Dec 2021 | Strasbourg, Grand Est, France | ||
Kaspard | $3M | 15 Jul 2021 | City of Brussels, Belgium | ||
Giiant Pharma | $11M | 21 May 2021 | Montréal, Quebec, Canada |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Ability biologics | $18M | 18 Jun 2024 | Quebec, Quebec, Canada | ||
Simmunome AI | $1M | 18 Sep 2023 | Montreal, Quebec, Canada | ||
Flare Systems | $2M | 30 Nov 2022 | Montreal, Quebec, Canada | ||
Domain Therapeutics | $46M | 10 May 2022 | France, Grand Est, France | ||
DrugBank | $7M | 11 Apr 2022 | Edmonton, Canada | ||
Cascador Health | $4M | 25 Mar 2022 | Oost-Vlaanderen, East Flanders, Belgium | ||
HypnoVR | $5M | 07 Dec 2021 | Strasbourg, Grand Est, France | ||
Kaspard | $3M | 15 Jul 2021 | City of Brussels, Belgium | ||
Giiant Pharma | $11M | 21 May 2021 | Montréal, Quebec, Canada |